Literature DB >> 6202570

Serum amylase during recovery from diabetic ketoacidosis.

J J Kjaergaard, N Salling, E Magid, J Ditzel.   

Abstract

To elucidate the mechanism of the hyperamylasaemia which is often found in diabetic ketoacidosis, 9 patients who were admitted in this disease state were studied. Blood samples were taken every 4 hours for the first 24 hours and thereafter daily for 7 days. Serum amylase concentration increased gradually in all patients, from 256 (65-1155) U/1 at the initial sampling to a maximum of 1160 (210-2670) U/1 20-24 hours later (p. greater than 0.01), median values with 95% confidence limits. Simultaneously, plasma inorganic phosphate concentrations decreased from a median value of 1.35 mmol/l to 0.45 mmol/l (p less than 0.01), and a significant negative correlation was found between the changes in these parameters in 5 patients. Isoenzyme analysis in 8 of the patients showed that hyperamylasaemia was of the "salivary type" in two and of the "pancreatic type" in two. None of the patients had clinical signs of pancreatitis. It is concluded that in diabetic ketoacidosis, the increase in serum amylase concentration observed in all patients is closely related to the action of insulin in the majority of these, and some possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202570

Source DB:  PubMed          Journal:  Diabete Metab        ISSN: 0338-1684


  4 in total

1.  Diabetic ketoacidosis: current views on pathogenesis and treatment.

Authors:  U Keller
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

2.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis.

Authors:  Jørn Ditzel; Hans-Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2010-09-20       Impact factor: 3.168

3.  Low serum amylase in association with metabolic syndrome and diabetes: A community-based study.

Authors:  Kei Nakajima; Tohru Nemoto; Toshitaka Muneyuki; Masafumi Kakei; Hiroshi Fuchigami; Hiromi Munakata
Journal:  Cardiovasc Diabetol       Date:  2011-04-17       Impact factor: 9.951

Review 4.  Changes in Salivary Amylase and Glucose in Diabetes: A Scoping Review.

Authors:  Pilar Pérez-Ros; Emmanuel Navarro-Flores; Ivan Julián-Rochina; Francisco Miguel Martínez-Arnau; Omar Cauli
Journal:  Diagnostics (Basel)       Date:  2021-03-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.